Current status of beta‐thalassemia and its treatment strategies
Background Thalassemia is an inherited hematological disorder categorized by a decrease
or absence of one or more of the globin chains synthesis. Beta‐thalassemia is caused by …
or absence of one or more of the globin chains synthesis. Beta‐thalassemia is caused by …
Thalassaemia
Inherited haemoglobin disorders, including thalassaemia and sickle-cell disease, are the
most common monogenic diseases worldwide. Several clinical forms of α-thalassaemia and …
most common monogenic diseases worldwide. Several clinical forms of α-thalassaemia and …
β-Thalassemia
R Origa - Genetics in medicine, 2017 - nature.com
Abstract β-Thalassemia is caused by reduced (β+) or absent (β 0) synthesis of the β-globin
chains of hemoglobin. Three clinical and hematological conditions of increasing severity are …
chains of hemoglobin. Three clinical and hematological conditions of increasing severity are …
Clinical classification, screening and diagnosis for thalassemia
Over the past decade, our knowledge of the clinical diagnosis and management of
thalassemia has progressed extensively. In recent years, the most critical change in clinical …
thalassemia has progressed extensively. In recent years, the most critical change in clinical …
The role of iron repletion in adult iron deficiency anemia and other diseases
Iron deficiency anemia (IDA) is the most prevalent and treatable form of anemia worldwide.
The clinical management of patients with IDA requires a comprehensive understanding of …
The clinical management of patients with IDA requires a comprehensive understanding of …
Iron overload in human disease
RE Fleming, P Ponka - New England Journal of Medicine, 2012 - Mass Medical Soc
Iron Overload in Human Disease | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia
L Kautz, G Jung, X Du, V Gabayan… - Blood, The Journal …, 2015 - ashpublications.org
Inherited anemias with ineffective erythropoiesis, such as β-thalassemia, manifest
inappropriately low hepcidin production and consequent excessive absorption of dietary …
inappropriately low hepcidin production and consequent excessive absorption of dietary …
Non-transfusion-dependent thalassemias
KM Musallam, S Rivella, E Vichinsky… - …, 2013 - pmc.ncbi.nlm.nih.gov
Non-transfusion-dependent thalassemias include a variety of phenotypes that, unlike
patients with beta (β)-thalassemia major, do not require regular transfusion therapy for …
patients with beta (β)-thalassemia major, do not require regular transfusion therapy for …
Thalassaemia
Thalassaemia is one of the most common genetic diseases worldwide, with at least 60 000
severely affected individuals born every year. Individuals originating from tropical and …
severely affected individuals born every year. Individuals originating from tropical and …
[HTML][HTML] A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?
Beta-thalassaemia causes defective haemoglobin synthesis leading to ineffective
erythropoiesis, chronic haemolytic anaemia, and subsequent clinical complications. Blood …
erythropoiesis, chronic haemolytic anaemia, and subsequent clinical complications. Blood …